MS is an autoimmune disease in which the immune system mistakenly attacks normal tissues of the central nervous system. It afflicts more than 400,000 people in the United States and more than 2.5 million worldwide. Specifically, the disease in its early stages of relapsing-remitting disease (RRMS) is characterized by patients experiencing sudden onset of exacerbations (relapses) that remit within a few weeks only to occur again at unpredicted times in the future. This phase of the disease often lasts for many years, after which the disease evolves into the progressive forms of MS, with fewer relapses but more overt signs of disability resulting from irreversible damage to the fatty tissue called myelin that surrounds and protects nerve fibers. The ensuing destruction of these neuronal cells creates scarring (sclerosis) and interferes with the normal transmission of nerve impulses. This, in turn, leads to a variety of highly individualized and unpredictable neurological symptoms, ranging from movement and balance problems to vision impairment. It is believed that a subset of the specific class of white blood cells, CD4+ T-cells, that normally plays an important role in the immune system, becomes autoreactive inflammatory T-cells causing inflammation within the central nervous system and is principally responsible for the relapses and initiation of the neurodegeneration and progression of the disease.
Company profile
Ticker
OCHTQ
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Immune Response Corp
SEC CIK
Corporate docs
IRS number
330255679
Latest filings (excl ownership)
REVOKED
Registration or securities revoked
28 Jun 12
8-K
Entry into a Material Definitive Agreement
11 Feb 08
8-K
Entry into a Material Definitive Agreement
9 Jan 08
8-K
Entry into a Material Definitive Agreement
13 Dec 07
8-K
Entry into a Material Definitive Agreement
7 Nov 07
10-Q
2007 Q2
Quarterly report
2 Oct 07
8-K
Entry into a Material Definitive Agreement
2 Oct 07
8-K
Departure of Directors or Principal Officers
28 Aug 07
NT 10-Q
Notice of late quarterly filing
14 Aug 07
Latest ownership filings
No filings